{"id":29048,"date":"2026-02-07T18:38:18","date_gmt":"2026-02-07T18:38:18","guid":{"rendered":"https:\/\/www.globalresearch.co.kr\/insight\/gene-therapy-market-mordor\/"},"modified":"2026-03-27T04:20:10","modified_gmt":"2026-03-26T19:20:10","slug":"gene-therapy-market-mordor","status":"publish","type":"post","link":"https:\/\/www.globalresearch.co.kr\/insight\/gene-therapy-market-mordor\/","title":{"rendered":"\uc138\uacc4\uc758 \uc720\uc804\uc790 \uce58\ub8cc \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc810\uc720\uc728 \ubd84\uc11d &#8211; \uc131\uc7a5 \ub3d9\ud5a5 \ubc0f \uc804\ub9dd (2026-2031\ub144)"},"content":{"rendered":"<p><img decoding=\"async\" src=\"https:\/\/www.globalresearch.co.kr\/insight\/wp-content\/uploads\/2026\/02\/gene-therapy-market_1658806947876_Gene_Therapy_Market_-_Keyplayers.webp\" alt=\"Chart\" class=\"aligncenter size-full\" \/><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/www.globalresearch.co.kr\/insight\/wp-content\/uploads\/2026\/02\/gene-therapy-market-size-image-1767635495396.webp\" alt=\"Chart\" class=\"aligncenter size-full\" \/><\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-0\">1. \uc11c\ub860<\/p>\n<ul>\n<li class=\"toc-level-2\">1.1 \uc5f0\uad6c \uac00\uc815 \ubc0f \uc2dc\uc7a5 \uc815\uc758<\/li>\n<li class=\"toc-level-2\">1.2 \uc5f0\uad6c \ubc94\uc704<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-1\">2. \uc5f0\uad6c \ubc29\ubc95\ub860<\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-2\">3. \uc694\uc57d<\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-3\">4. \uc2dc\uc7a5 \ud604\ud669<\/p>\n<ul>\n<li class=\"toc-level-2\">4.1 \uc2dc\uc7a5 \uac1c\uc694<\/li>\n<li class=\"toc-level-2\">4.2 \uc2dc\uc7a5 \ub3d9\uc778\n<ul>\n<li class=\"toc-level-3\">4.2.1 \uc6d0\uc0f7 \uce58\ub8cc\uc81c \uc2b9\uc778 \uae09\uc99d<\/li>\n<li class=\"toc-level-3\">4.2.2 \ucd08\ud76c\uadc0 \uc9c8\ud658\uc5d0 \ub300\ud55c \ubcf4\ud5d8 \uc801\uc6a9 \ud655\ub300<\/li>\n<li class=\"toc-level-3\">4.2.3 \uc81c\uc870 \ud50c\ub7ab\ud3fc \ud45c\uc900\ud654 (AAV &amp; LV)<\/li>\n<li class=\"toc-level-3\">4.2.4 \ubca4\ucc98 \ubc0f SPAC \uc790\uae08 \uc870\ub2ec \ud30c\uc774\ud504\ub77c\uc778 \uc99d\uac00<\/li>\n<li class=\"toc-level-3\">4.2.5 CRISPR \uae30\ubc18 \uc0dd\uccb4 \ub0b4 \ud3b8\uc9d1 \ud601\uc2e0<\/li>\n<li class=\"toc-level-3\">4.2.6 \ud76c\uadc0 \uc9c8\ud658 \uc720\uc804\uc790 \uce58\ub8cc\uc81c \ud3ec\ud568 \uc99d\uac00<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">4.3 \uc2dc\uc7a5 \uc81c\uc57d\n<ul>\n<li class=\"toc-level-3\">4.3.1 \ub192\uc740 \ub9e4\ucd9c\uc6d0\uac00 \ubc0f 6\uc790\ub9ac \uac00\uaca9 \ubc18\ubc1c<\/li>\n<li class=\"toc-level-3\">4.3.2 \ubcf5\uc7a1\ud55c \uc7a5\uae30 \uc548\uc804\uc131 \ubaa8\ub2c8\ud130\ub9c1 \uc758\ubb34<\/li>\n<li class=\"toc-level-3\">4.3.3 \uc804 \uc138\uacc4 \ubc14\uc774\ub7ec\uc2a4 \ubca1\ud130 \uc0dd\uc0b0 \ub2a5\ub825 \ubcd1\ubaa9 \ud604\uc0c1<\/li>\n<li class=\"toc-level-3\">4.3.4 \uc720\uc804\uc790 \ud3b8\uc9d1 \ud398\uc774\ub85c\ub4dc\uc5d0 \ub300\ud55c \ud2b9\ud5c8 \ubc00\uc9d1 \ud604\uc0c1<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">4.4 \uac00\uce58 \/ \uacf5\uae09\ub9dd \ubd84\uc11d<\/li>\n<li class=\"toc-level-2\">4.5 \uaddc\uc81c \ud658\uacbd<\/li>\n<li class=\"toc-level-2\">4.6 \uae30\uc220 \uc804\ub9dd<\/li>\n<li class=\"toc-level-2\">4.7 \ud3ec\ud130\uc758 5\uac00\uc9c0 \uacbd\uc7c1 \uc694\uc778 \ubd84\uc11d\n<ul>\n<li class=\"toc-level-3\">4.7.1 \uc2e0\uaddc \uc9c4\uc785\uc790\uc758 \uc704\ud611<\/li>\n<li class=\"toc-level-3\">4.7.2 \uad6c\ub9e4\uc790\uc758 \uad50\uc12d\ub825<\/li>\n<li class=\"toc-level-3\">4.7.3 \uacf5\uae09\uc790\uc758 \uad50\uc12d\ub825<\/li>\n<li class=\"toc-level-3\">4.7.4 \ub300\uccb4\uc7ac\uc758 \uc704\ud611<\/li>\n<li class=\"toc-level-3\">4.7.5 \uacbd\uc7c1 \uac15\ub3c4<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-4\">5. \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc131\uc7a5 \uc608\uce21<\/p>\n<ul>\n<li class=\"toc-level-2\">5.1 \uce58\ub8cc \uc720\ud615\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.1.1 \uc0dd\uccb4 \ub0b4<\/li>\n<li class=\"toc-level-3\">5.1.2 \uc0dd\uccb4 \uc678<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.2 \ubca1\ud130 \uc720\ud615\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.2.1 \ubc14\uc774\ub7ec\uc2a4 \ubca1\ud130<\/li>\n<li class=\"toc-level-4\">5.2.1.1 \uc544\ub370\ub178-\uad00\ub828 \ubc14\uc774\ub7ec\uc2a4<\/li>\n<li class=\"toc-level-4\">5.2.1.2 \ub80c\ud2f0\ubc14\uc774\ub7ec\uc2a4<\/li>\n<li class=\"toc-level-4\">5.2.1.3 \uc544\ub370\ub178\ubc14\uc774\ub7ec\uc2a4<\/li>\n<li class=\"toc-level-4\">5.2.1.4 \ub808\ud2b8\ub85c\ubc14\uc774\ub7ec\uc2a4 &amp; \u03b3-\ub808\ud2b8\ub85c\ubc14\uc774\ub7ec\uc2a4<\/li>\n<li class=\"toc-level-4\">5.2.1.5 \uae30\ud0c0 \ubc14\uc774\ub7ec\uc2a4<\/li>\n<li class=\"toc-level-3\">5.2.2 \ube44\ubc14\uc774\ub7ec\uc2a4 \ubca1\ud130<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.3 \uc801\uc751\uc99d\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.3.1 \uc885\uc591\ud559<\/li>\n<li class=\"toc-level-3\">5.3.2 \ud76c\uadc0 \uc720\uc804 \uc9c8\ud658<\/li>\n<li class=\"toc-level-3\">5.3.3 \uc548\uacfc<\/li>\n<li class=\"toc-level-3\">5.3.4 \ud608\uc561\ud559<\/li>\n<li class=\"toc-level-3\">5.3.5 \uc2e0\uacbd\ud559<\/li>\n<li class=\"toc-level-3\">5.3.6 \uc2ec\ud608\uad00 &amp; \uae30\ud0c0<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.4 \uc804\ub2ec \ubc29\ubc95\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.4.1 \uc804\uc2e0 \ud22c\uc5ec<\/li>\n<li class=\"toc-level-3\">5.4.2 \uad6d\uc18c \ud22c\uc5ec<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.5 \ucd5c\uc885 \uc0ac\uc6a9\uc790\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.5.1 \ubcd1\uc6d0 &amp; \uc804\ubb38 \ud074\ub9ac\ub2c9<\/li>\n<li class=\"toc-level-3\">5.5.2 \ud559\uc220 &amp; \uc5f0\uad6c \uae30\uad00<\/li>\n<li class=\"toc-level-3\">5.5.3 \uae30\ud0c0 \ucd5c\uc885 \uc0ac\uc6a9\uc790<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.6 \uc9c0\uc5ed\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.6.1 \ubd81\ubbf8<\/li>\n<li class=\"toc-level-4\">5.6.1.1 \ubbf8\uad6d<\/li>\n<li class=\"toc-level-4\">5.6.1.2 \uce90\ub098\ub2e4<\/li>\n<li class=\"toc-level-4\">5.6.1.3 \uba55\uc2dc\ucf54<\/li>\n<li class=\"toc-level-3\">5.6.2 \uc720\ub7fd<\/li>\n<li class=\"toc-level-4\">5.6.2.1 \ub3c5\uc77c<\/li>\n<li class=\"toc-level-4\">5.6.2.2 \uc601\uad6d<\/li>\n<li class=\"toc-level-4\">5.6.2.3 \ud504\ub791\uc2a4<\/li>\n<li class=\"toc-level-4\">5.6.2.4 \uc774\ud0c8\ub9ac\uc544<\/li>\n<li class=\"toc-level-4\">5.6.2.5 \uc2a4\ud398\uc778<\/li>\n<li class=\"toc-level-4\">5.6.2.6 \uae30\ud0c0 \uc720\ub7fd<\/li>\n<li class=\"toc-level-3\">5.6.3 \uc544\uc2dc\uc544-\ud0dc\ud3c9\uc591<\/li>\n<li class=\"toc-level-4\">5.6.3.1 \uc911\uad6d<\/li>\n<li class=\"toc-level-4\">5.6.3.2 \uc77c\ubcf8<\/li>\n<li class=\"toc-level-4\">5.6.3.3 \uc778\ub3c4<\/li>\n<li class=\"toc-level-4\">5.6.3.4 \ud638\uc8fc<\/li>\n<li class=\"toc-level-4\">5.6.3.5 \ub300\ud55c\ubbfc\uad6d<\/li>\n<li class=\"toc-level-4\">5.6.3.6 \uae30\ud0c0 \uc544\uc2dc\uc544-\ud0dc\ud3c9\uc591<\/li>\n<li class=\"toc-level-3\">5.6.4 \uc911\ub3d9 &amp; \uc544\ud504\ub9ac\uce74<\/li>\n<li class=\"toc-level-4\">5.6.4.1 GCC<\/li>\n<li class=\"toc-level-4\">5.6.4.2 \ub0a8\uc544\ud504\ub9ac\uce74<\/li>\n<li class=\"toc-level-4\">5.6.4.3 \uae30\ud0c0 \uc911\ub3d9 &amp; \uc544\ud504\ub9ac\uce74<\/li>\n<li class=\"toc-level-3\">5.6.5 \ub0a8\ubbf8<\/li>\n<li class=\"toc-level-4\">5.6.5.1 \ube0c\ub77c\uc9c8<\/li>\n<li class=\"toc-level-4\">5.6.5.2 \uc544\ub974\ud5e8\ud2f0\ub098<\/li>\n<li class=\"toc-level-4\">5.6.5.3 \uae30\ud0c0 \ub0a8\ubbf8<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-5\">6. \uacbd\uc7c1 \ud658\uacbd<\/p>\n<ul>\n<li class=\"toc-level-2\">6.1 \uc2dc\uc7a5 \uc9d1\uc911\ub3c4<\/li>\n<li class=\"toc-level-2\">6.2 \uc2dc\uc7a5 \uc810\uc720\uc728 \ubd84\uc11d<\/li>\n<li class=\"toc-level-2\">6.3 \uae30\uc5c5 \ud504\ub85c\ud544 (\uae00\ub85c\ubc8c \uac1c\uc694, \uc2dc\uc7a5 \uac1c\uc694, \ud575\uc2ec \ubd80\ubb38, \uc7ac\ubb34, \uc804\ub7b5 \uc815\ubcf4, \uc2dc\uc7a5 \uc21c\uc704\/\uc810\uc720\uc728, \uc81c\ud488 \ubc0f \uc11c\ube44\uc2a4, \ucd5c\uadfc \uac1c\ubc1c \ud3ec\ud568)\n<ul>\n<li class=\"toc-level-3\">6.3.1 \uc554\uc820(Amgen Inc.)<\/li>\n<li class=\"toc-level-3\">6.3.2 \ube54 \ud14c\ub77c\ud4e8\ud2f1\uc2a4(Beam Therapeutics)<\/li>\n<li class=\"toc-level-3\">6.3.3 \ube14\ub8e8\ubc84\ub4dc \ubc14\uc774\uc624(bluebird bio Inc.)<\/li>\n<li class=\"toc-level-3\">6.3.4 \ube0c\ub9ac\uc2a4\ud1a8 \ub9c8\uc774\uc5b4\uc2a4 \uc2a4\ud045(Bristol Myers Squibb)<\/li>\n<li class=\"toc-level-3\">6.3.5 \ubc14\uc774\uc624\uc820(Biogen Inc.)<\/li>\n<li class=\"toc-level-3\">6.3.6 \ud06c\ub9ac\uc2a4\ud37c \ud14c\ub77c\ud4e8\ud2f1\uc2a4(CRISPR Therapeutics)<\/li>\n<li class=\"toc-level-3\">6.3.7 \uc5d0\ub514\ud0c0\uc2a4 \uba54\ub514\uc2a8(Editas Medicine)<\/li>\n<li class=\"toc-level-3\">6.3.8 \ud504\ub9ac\ub77c\uc778 \ud14c\ub77c\ud4e8\ud2f1\uc2a4(Freeline Therapeutics)<\/li>\n<li class=\"toc-level-3\">6.3.9 \uae38\ub9ac\uc5b4\ub4dc \uc0ac\uc774\uc5b8\uc2a4(Gilead Sciences Inc.)<\/li>\n<li class=\"toc-level-3\">6.3.10 \uc778\ud154\ub9ac\uc544 \ud14c\ub77c\ud4e8\ud2f1\uc2a4(Intellia Therapeutics)<\/li>\n<li class=\"toc-level-3\">6.3.11 \ub85c\uc9c1\ubc14\uc774\uc624 \ud14c\ub77c\ud4e8\ud2f1\uc2a4(LogicBio Therapeutics)<\/li>\n<li class=\"toc-level-3\">6.3.12 \uba54\uc774\ub77cGTx(MeiraGTx)<\/li>\n<li class=\"toc-level-3\">6.3.13 \uba38\uc2a4\ud0f1 \ubc14\uc774\uc624(Mustang Bio)<\/li>\n<li class=\"toc-level-3\">6.3.14 \ub178\ubc14\ud2f0\uc2a4(Novartis AG)<\/li>\n<li class=\"toc-level-3\">6.3.15 \uc624\ucc28\ub4dc \ud14c\ub77c\ud4e8\ud2f1\uc2a4(Orchard Therapeutics)<\/li>\n<li class=\"toc-level-3\">6.3.16 \ud328\uc2dc\uc9c0 \ubc14\uc774\uc624(Passage Bio)<\/li>\n<li class=\"toc-level-3\">6.3.17 \ud654\uc774\uc790(Pfizer Inc.)<\/li>\n<li class=\"toc-level-3\">6.3.18 \ub9ac\uc820\uc5d1\uc2a4\ubc14\uc774\uc624(Regenxbio)<\/li>\n<li class=\"toc-level-3\">6.3.19 \uc0c1\uac00\ubaa8 \ud14c\ub77c\ud4e8\ud2f1\uc2a4(Sangamo Therapeutics)<\/li>\n<li class=\"toc-level-3\">6.3.20 \uc0ac\ub819\ud0c0 \ud14c\ub77c\ud4e8\ud2f1\uc2a4(Sarepta Therapeutics)<\/li>\n<li class=\"toc-level-3\">6.3.21 \uc2a4\ud30c\ud06c \ud14c\ub77c\ud4e8\ud2f1\uc2a4(Spark Therapeutics)<\/li>\n<li class=\"toc-level-3\">6.3.22 \ub2e4\ucf00\ub2e4 \uc81c\uc57d(Takeda Pharmaceutical)<\/li>\n<li class=\"toc-level-3\">6.3.23 \uc720\ub2c8\ud050\uc5b4(uniQure N.V.)<\/li>\n<li class=\"toc-level-3\">6.3.24 \ube44\uc81c\ub124\ub860(ViGeneron)<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-6\">7. \uc2dc\uc7a5 \uae30\ud68c \ubc0f \ubbf8\ub798 \uc804\ub9dd<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\uc720\uc804\uc790 \uce58\ub8cc \uc2dc\uc7a5 \uac1c\uc694 (2026-2031\ub144 \uc608\uce21)<\/p>\n<p>\uc720\uc804\uc790 \uce58\ub8cc \uc2dc\uc7a5\uc740 2026\ub144 100\uc5b5 4\ucc9c\ub9cc \ub2ec\ub7ec\uc5d0\uc11c 2031\ub144 258\uc5b5 9\ucc9c\ub9cc \ub2ec\ub7ec \uaddc\ubaa8\ub85c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub418\uba70, \uc608\uce21 \uae30\uac04(2026-2031\ub144) \ub3d9\uc548 \uc5f0\ud3c9\uade0 \uc131\uc7a5\ub960(CAGR) 20.86%\ub97c \uae30\ub85d\ud560 \uc804\ub9dd\uc785\ub2c8\ub2e4. \uc774\ub294 \uc720\uc804\uc790 \uce58\ub8cc\uac00 \uc2e4\ud5d8\uc801 \uce58\ub8cc\ubc95\uc5d0\uc11c \uc0c1\uc5c5\uc801\uc73c\ub85c \ud655\uc7a5 \uac00\ub2a5\ud55c \uce58\ub8cc \ubd84\uc57c\ub85c \uc804\ud658\ub418\uace0 \uc788\uc74c\uc744 \ubcf4\uc5ec\uc90d\ub2c8\ub2e4. \uc774\ub7ec\ud55c \uc131\uc7a5\uc740 \uc77c\ud68c\uc131 \uc644\uce58 \uce58\ub8cc\ubc95 \uc2b9\uc778 \uac00\uc18d\ud654, \uc131\uacfc \uae30\ubc18 \uc0c1\ud658 \ubaa8\ub378 \ud655\ub300, \ud50c\ub7ab\ud3fc \uc81c\uc870 \ud6a8\uc728\uc131 \uc99d\ub300 \ub4f1 \uc5ec\ub7ec \uc694\uc778\uc5d0 \uc758\ud574 \uc8fc\ub3c4\ub418\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ubd81\ubbf8 \uc9c0\uc5ed\uc774 \uac00\uc7a5 \ud070 \uc2dc\uc7a5 \uc810\uc720\uc728\uc744 \uc720\uc9c0\ud558\uace0 \uc788\uc73c\uba70, \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591 \uc9c0\uc5ed\uc740 \uac00\uc7a5 \ube60\ub978 \uc131\uc7a5\ub960\uc744 \ubcf4\uc77c \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. \uc2dc\uc7a5 \uc9d1\uc911\ub3c4\ub294 \uc911\uac04 \uc218\uc900\uc785\ub2c8\ub2e4.<\/p>\n<p>\ubcf8 \ubcf4\uace0\uc11c\ub294 \uce58\ub8cc \uc720\ud615(\uc0dd\uccb4 \ub0b4, \uc0dd\uccb4 \uc678), \ubca1\ud130 \uc720\ud615(\ubc14\uc774\ub7ec\uc2a4 \ubca1\ud130, \ube44\ubc14\uc774\ub7ec\uc2a4 \ubca1\ud130), \uc801\uc751\uc99d(\uc885\uc591\ud559, \ud76c\uadc0 \uc720\uc804 \uc9c8\ud658 \ub4f1), \uc804\ub2ec \ubc29\uc2dd(\uc804\uc2e0, \uad6d\uc18c), \ucd5c\uc885 \uc0ac\uc6a9\uc790(\ubcd1\uc6d0 \ubc0f \uc804\ubb38 \ud074\ub9ac\ub2c9 \ub4f1), \uadf8\ub9ac\uace0 \uc9c0\uc5ed(\ubd81\ubbf8, \uc720\ub7fd, \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591, \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74, \ub0a8\ubbf8)\ubcc4\ub85c \uc2dc\uc7a5\uc744 \uc138\ubd84\ud654\ud558\uc5ec \ubd84\uc11d\ud569\ub2c8\ub2e4.<\/p>\n<p># \uc8fc\uc694 \uc2dc\uc7a5 \ub3d9\ud5a5 \ubc0f \ud1b5\ucc30\ub825<\/p>\n<p>1. \uc2dc\uc7a5 \uc131\uc7a5 \ub3d9\ub825:<\/p>\n<p>*   \uc77c\ud68c\uc131 \uc644\uce58 \uce58\ub8cc\ubc95 \uc2b9\uc778 \uc99d\uac00: 2024-2025\ub144 \uaddc\uc81c \ub2f9\uad6d\uc740 \uc704\uc2a4\ucf67-\uc54c\ub4dc\ub9ac\uce58 \uc99d\ud6c4\uad70 \uce58\ub8cc\uc81c Waskyra, \ucc99\uc218\uc131 \uadfc\uc704\ucd95\uc99d \uce58\ub8cc\uc81c Itvisma, \uacb8\uc0c1 \uc801\ud608\uad6c \ube48\ud608\uc99d \uce58\ub8cc\uc81c Casgevy \ub4f1 \uc5ec\ub7ec \uce58\ub8cc\ubc95\uc758 \uc2b9\uc778 \uc808\ucc28\ub97c \uac00\uc18d\ud654\ud588\uc2b5\ub2c8\ub2e4. \uc774\ub7ec\ud55c \uce58\ub8cc\ubc95\ub4e4\uc740 \uc7a5\uae30\uc801\uc778 \ud6a8\ub2a5\uc744 \uc785\uc99d\ud558\uba70, \ubcf4\ud5d8\uc0ac\ub4e4\uc740 \uc77c\ud68c\uc131 \uac1c\uc785\uc774 \uc218\uc2ed \ub144\uac04\uc758 \ub9cc\uc131 \uc9c8\ud658 \uad00\ub9ac \ube44\uc6a9\uc744 \uc0c1\uc1c4\ud560 \uc218 \uc788\uc74c\uc744 \uc778\uc815\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc77c\ubcf8\uc758 \uc0ac\ud0a4\uac00\ucf00(Sakigake) \uacbd\ub85c \ud655\uc7a5 \ub610\ud55c \uc774\ub7ec\ud55c \uae00\ub85c\ubc8c \ucd94\uc138\ub97c \ub4b7\ubc1b\uce68\ud569\ub2c8\ub2e4.<br \/>\n*   \ucd08\ud76c\uadc0 \uc9c8\ud658\uc5d0 \ub300\ud55c \uc0c1\ud658 \ud655\ub300: \ubbf8\uad6d \uc0c1\uc5c5 \uacc4\uc57d\uc758 \uc57d 40%\uac00 \uc131\uacfc \uae30\ubc18 \ubaa8\ub378\uc744 \ub530\ub974\uace0 \uc788\uc73c\uba70, CMS\uc758 \uc138\ud3ec \ubc0f \uc720\uc804\uc790 \uce58\ub8cc \uc811\uadfc \ubaa8\ub378\uc740 35\uac1c \uba54\ub514\ucf00\uc774\ub4dc \ud504\ub85c\uadf8\ub7a8\uc5d0 \uc801\uc6a9\ub418\uc5b4 \uc81c\uc870\uc5c5\uccb4\uc640 \uc7ac\uc815\uc801 \uc704\ud5d8\uc744 \uacf5\uc720\ud569\ub2c8\ub2e4. \uc720\ub7fd\uc740 \uc5ec\uc804\ud788 \ubd84\uc5f4\ub418\uc5b4 \uc788\uc9c0\ub9cc, \ud504\ub791\uc2a4\uac00 \uc878\uac90\uc2a4\ub9c8(Zolgensma)\uc758 210\ub9cc \ub2ec\ub7ec \ube44\uc6a9\uc744 5\ub144\uc5d0 \uac78\uccd0 \ubd84\ud560 \uc9c0\ubd88\ud558\ub294 \ub4f1 \ud560\ubd80 \uacb0\uc81c\ub97c \uc2dc\ub3c4\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc2e4\uc81c \uc878\uac90\uc2a4\ub9c8 \uc0ac\uc6a9 \ub370\uc774\ud130\ub294 \uce58\ub8cc\ubc1b\uc740 \uc5b4\ub9b0\uc774\uc758 95%\uac00 5\ub144 \ucd94\uc801 \uad00\ucc30 \uc2dc \uc6b4\ub3d9 \ubc1c\ub2ec \uc774\uc815\ud45c\ub97c \uc720\uc9c0\ud568\uc744 \ubcf4\uc5ec\uc8fc\uba70, \uc131\uacfc \uae30\ubc18 \uc9c0\ubd88 \uc81c\ub3c4\uc758 \uac00\uce58\ub97c \uac15\ud654\ud569\ub2c8\ub2e4.<br \/>\n*   \uc81c\uc870 \ud50c\ub7ab\ud3fc \ud45c\uc900\ud654 (AAV &#038; LV): \ub860\uc790(Lonza)\uc640 \uce74\ud0c8\ub80c\ud2b8(Catalent)\uc758 \ub300\uaddc\ubaa8 \uc2dc\uc124 \ud22c\uc790\ub294 \ubaa8\ub4c8\ud615 \ubc14\uc774\uc624\ub9ac\uc561\ud130\uc758 \ud65c\uc6a9\uc744 \uac00\ub2a5\ud558\uac8c \ud558\uc5ec \uacf5\uc815 \uc804\ud658 \uc5c6\uc774 \uc5ec\ub7ec \ucea0\ud398\uc778\uc5d0 \uc720\uc5f0\ud558\uac8c \ub300\uc751\ud560 \uc218 \uc788\ub3c4\ub85d \ud569\ub2c8\ub2e4. \ubc00\ub9ac\ud3ec\uc5b4\uc2dc\uadf8\ub9c8(MilliporeSigma)\uc758 AAV-MAX \uc2dc\uc2a4\ud15c\uc740 \ubd80\ucc29 \ubc30\uc591 \uc694\uad6c \uc0ac\ud56d\uc744 \uc81c\uac70\ud558\uc5ec \uc0c1\ub958 \ube44\uc6a9\uc744 \uc808\ubc18\uc73c\ub85c \uc904\uc600\uace0, \ubc14\uc774\ub7f4\uc820(Viralgen)\uc758 Pro10\u2122 \ud50c\ub7ab\ud3fc\uc740 \ubc30\uce58 \uc2e4\ud328\uc728\uc744 5% \ubbf8\ub9cc\uc73c\ub85c \ub0ae\ucdc4\uc2b5\ub2c8\ub2e4. \uc0bc\uc131\ubc14\uc774\uc624\ub85c\uc9c1\uc2a4\uc758 \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591 \uc9c0\uc5ed \ucd5c\ucd08 \ub300\uaddc\ubaa8 AAV \uacf5\uc7a5 \ucd94\uac00\ub294 \uacf5\uae09\ub9dd\uc758 \uc9c0\ub9ac\uc801 \ub2e4\ubcc0\ud654\ub97c \uc608\uace0\ud569\ub2c8\ub2e4. 2024\ub144 FDA-EMA \uacf5\ub3d9 \uc9c0\uce68\uc740 AAV \ubd84\uc11d\ubc95\uc744 \uc870\ud654\uc2dc\ucf1c \uc911\ubcf5\ub41c \uac80\uc99d \ube44\uc6a9\uc744 \uc9c1\uc811\uc801\uc73c\ub85c \uc808\uac10\ud569\ub2c8\ub2e4.<br \/>\n*   \ubca4\ucc98 \ubc0f SPAC \uc790\uae08 \uc870\ub2ec \ud30c\uc774\ud504\ub77c\uc778 \uc99d\uac00: 2024\ub144 \ubca4\ucc98 \ud22c\uc790\uc790\ub4e4\uc740 32\uc5b5 \ub2ec\ub7ec\ub97c \ud22c\uc790\ud588\uc73c\uba70, \uc774 \uc911 70%\uac00 \uc784\uc0c1 2\uc0c1 \uc774\uc0c1 \uc790\uc0b0\uc5d0 \ud560\ub2f9\ub418\uc5b4 \uc784\uc0c1 \uc704\ud5d8 \uac10\uc18c\uc5d0 \ub300\ud55c \ub192\uc740 \uc218\uc694\ub97c \ub098\ud0c0\ub0c8\uc2b5\ub2c8\ub2e4. \ud504\ub77c\uc784 \uba54\ub514\uc2a8(Prime Medicine)\uacfc \ud1b0 \ubc14\uc774\uc624\uc0ac\uc774\uc5b8\uc2a4(Tome Biosciences)\uc758 \ub300\uaddc\ubaa8 \ud22c\uc790\ub294 \ucc28\ubcc4\ud654\ub41c \uc720\uc804\uc790 \ud3b8\uc9d1 \uae30\uc220\uc5d0 \ub300\ud55c \uae30\ub300\ub97c \ubcf4\uc5ec\uc90d\ub2c8\ub2e4.<\/p>\n<p>2. \uc2dc\uc7a5 \uc81c\uc57d \uc694\uc778:<\/p>\n<p>*   \ub192\uc740 \uc81c\uc870\uc6d0\uac00(COGS) \ubc0f \uace0\uac00 \ub17c\ub780: \ubc14\uc774\ub7ec\uc2a4 \ubca1\ud130 \ubc30\uce58\ub2f9 50\ub9cc~200\ub9cc \ub2ec\ub7ec\uc5d0 \ub2ec\ud558\ub294 \ube44\uc6a9\uc740 \ub80c\uba5c\ub514(Lenmeldy)\uc758 425\ub9cc \ub2ec\ub7ec\uc640 \uac19\uc740 \ub192\uc740 \uc815\uac00\ub97c \ucd08\ub798\ud558\uc5ec \ubbf8\uad6d \uc0c1\uc6d0 \uc7ac\uc815 \uccad\ubb38\ud68c\uc640 NICE\uc758 \uac70\ubd80\ub85c \uc774\uc5b4\uc84c\uc2b5\ub2c8\ub2e4. \ucea0\ud398\uc778\ub2f9 30~70%\uc5d0 \uc774\ub974\ub294 \uc218\uc728 \ubcc0\ub3d9\uc131\uc740 \uacfc\uc789 \uc0dd\uc0b0 \ubc0f \ud3d0\uae30\ub97c \uc57c\uae30\ud569\ub2c8\ub2e4. \uc5f0\uc18d \uc81c\uc870 \uae30\uc220\uc740 \ube44\uc6a9\uc744 50% \uc808\uac10\ud560 \uc218 \uc788\uc9c0\ub9cc, 2027\ub144 \uc774\uc804\uc5d0\ub294 \uc0c1\uc5c5\uc801 \uaddc\ubaa8\uc5d0 \ub3c4\ub2ec\ud558\uae30 \uc5b4\ub824\uc6b8 \uac83\uc73c\ub85c \ubcf4\uc785\ub2c8\ub2e4. \ube14\ub8e8\ubc84\ub4dc \ubc14\uc774\uc624(Bluebird Bio)\uac00 \uc0c1\ud658 \uc2e4\ud328\ub85c \uc778\ud574 \uc720\ub7fd\uc5d0\uc11c \uc9c4\ud14c\uae00\ub85c(Zynteglo)\ub97c \ucca0\ud68c\ud55c \uc0ac\ub840\ub294 \ub192\uc740 \uac00\uaca9\uc774 \ucd08\ub798\ud558\ub294 \uc2e4\uc874\uc801 \uc704\ud5d8\uc744 \ubcf4\uc5ec\uc90d\ub2c8\ub2e4.<br \/>\n*   \ubcf5\uc7a1\ud55c \uc7a5\uae30 \uc548\uc804\uc131 \ubaa8\ub2c8\ud130\ub9c1 \uc758\ubb34: FDA\ub294 \ud1b5\ud569 \ubca1\ud130\uc5d0 \ub300\ud574 \uc5f0\uac04 \ub610\ub294 3\ub144\ub9c8\ub2e4 \ubc29\ubb38 \ubc0f \ud608\uc561\uc554 \uac80\uc9c4\uc744 \ud3ec\ud568\ud55c 15\ub144\uac04\uc758 \ud658\uc790 \uac10\uc2dc\ub97c \uc694\uad6c\ud558\uba70, \uc774\ub294 \uc18c\uaddc\ubaa8 \uae30\uc5c5\uc5d0 \uc5f0\uac04 500\ub9cc~1000\ub9cc \ub2ec\ub7ec\uc758 \ube44\uc6a9 \ubd80\ub2f4\uc744 \uc548\uaca8\uc90d\ub2c8\ub2e4. EMA\uc758 \uc704\ud5d8 \uad00\ub9ac \uacc4\ud68d\uc740 \uc644\uc804\ud55c \uc2dc\ud310 \ud5c8\uac00\ub97c \ubc1b\uc744 \ub54c\uae4c\uc9c0 \ubd80\ub2f4\uc744 \uc5f0\uc7a5\ud558\uc5ec \uc190\uc775\ubd84\uae30\uc810 \ub3c4\ub2ec \uc2dc\uae30\ub97c \uc9c0\uc5f0\uc2dc\ud0b5\ub2c8\ub2e4.<br \/>\n*   \uae00\ub85c\ubc8c \ubc14\uc774\ub7ec\uc2a4 \ubca1\ud130 \uc0dd\uc0b0 \ubcd1\ubaa9 \ud604\uc0c1: \ubd81\ubbf8 \ubc0f \uc720\ub7fd \uc81c\uc870 \ud5c8\ube0c\uc5d0 \uc9d1\uc911\ub41c \uc0dd\uc0b0 \ubcd1\ubaa9 \ud604\uc0c1\uc740 \uc2dc\uc7a5 \uc131\uc7a5\uc744 \uc81c\uc57d\ud569\ub2c8\ub2e4.<br \/>\n*   \uc720\uc804\uc790 \ud3b8\uc9d1 \ud398\uc774\ub85c\ub4dc\uc5d0 \ub300\ud55c \ud2b9\ud5c8 \ubc00\uc9d1: \uc720\uc804\uc790 \ud3b8\uc9d1 \ud398\uc774\ub85c\ub4dc\uc5d0 \ub300\ud55c \ud2b9\ud5c8 \uacbd\uc7c1 \uc2ec\ud654\ub294 \uc2dc\uc7a5 \uc9c4\uc785 \uc7a5\ubcbd\uc744 \ub192\uc785\ub2c8\ub2e4.<\/p>\n<p># \uc138\uadf8\uba3c\ud2b8 \ubd84\uc11d<\/p>\n<p>*   \uce58\ub8cc \uc720\ud615\ubcc4: \uc0dd\uccb4 \ub0b4(in vivo) \uc811\uadfc\ubc95\uc740 2025\ub144 \ub9e4\ucd9c\uc758 67.31%\ub97c \ucc28\uc9c0\ud558\uba70 \uac04 \ubc0f \uc804\uc2e0 \uc801\uc6a9 \ubd84\uc57c\uc5d0\uc11c \uc9c0\ubc30\uc801\uc785\ub2c8\ub2e4. \uadf8\ub7ec\ub098 \uc0dd\uccb4 \uc678(ex vivo) \uce58\ub8cc\ubc95\uc740 CRISPR \uae30\ubc18 \ub3d9\uc885 CAR-T \uc124\uacc4\uc5d0 \ud798\uc785\uc5b4 21.97%\uc758 \uac00\uc7a5 \ube60\ub978 CAGR\ub85c \uc2dc\uc7a5\uc744 \ub2a5\uac00\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. FDA\uc758 CMC \uc9c0\uce68\uc740 \uaddc\uc81c \ubd88\ud655\uc2e4\uc131\uc744 \uc904\uc600\uc73c\uba70, \uc774\ub3d9\uc2dd \ud074\ub9b0\ub8f8\uacfc \uac19\uc740 \ube44\uc6a9 \ud6a8\uc728\uc801\uc778 \ud604\uc7a5 \uc81c\uc870 \ubc29\uc2dd\uc774 \ub3c4\uc785\ub418\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   \ubca1\ud130 \uc720\ud615\ubcc4: \ubc14\uc774\ub7ec\uc2a4 \ubca1\ud130\ub294 AAV\uc640 LV\ub97c \uae30\ubc18\uc73c\ub85c 2025\ub144 \ub9e4\ucd9c\uc758 74.83%\ub97c \ucc28\uc9c0\ud588\uc2b5\ub2c8\ub2e4. \uadf8\ub7ec\ub098 \ucd5c\uc801\ud654\ub41c \uc9c0\uc9c8 \ub098\ub178\uc785\uc790(LNP)\ub97c \ud1b5\ud574 \ud6a8\ub2a5 \uaca9\ucc28\ub97c \uc904\uc774\uace0 \uc788\ub294 \ube44\ubc14\uc774\ub7ec\uc2a4 \ubca1\ud130\ub294 23.41%\uc758 CAGR\ub85c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. MaxCyte\uc758 \uc804\uae30\ucc9c\uacf5\ubc95\uc740 50\uac1c \uc774\uc0c1\uc758 \uc784\uc0c1 \uc2dc\ud5d8\uc744 \uc9c0\uc6d0\ud558\uba70, Touchlight\uc758 \ud6a8\uc18c DNA\ub294 \ud50c\ub77c\uc2a4\ubbf8\ub4dc \ub300\uc548\uc73c\ub85c \ubd80\uc0c1\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   \uc801\uc751\uc99d\ubcc4: \uc885\uc591\ud559\uc740 CAR-T \uce58\ub8cc\ubc95\uc758 \ubc1c\uc804\uc73c\ub85c 2025\ub144 \ub9e4\ucd9c\uc758 44.15%\ub97c \ucc28\uc9c0\ud558\uba70 \uc9c0\uc18d\uc801\uc778 \uae30\uc5ec\ub97c \ud560 \uac83\uc73c\ub85c \ubcf4\uc785\ub2c8\ub2e4. \uc2e0\uacbd\ud559 \ubd84\uc57c\ub294 \ub1cc\ud608\uad00 \uc7a5\ubcbd\uc744 \uc6b0\ud68c\ud558\ub294 \ucc99\uc218\uac15 \ub0b4 AAV \uc804\ub2ec \ub355\ubd84\uc5d0 22.71%\uc758 CAGR\ub85c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4. \uc548\uacfc \ubd84\uc57c\ub294 \uba74\uc5ed \ud2b9\uad8c \ub355\ubd84\uc5d0 \uc218\uc775\uc131 \uc788\ub294 \ud2c8\uc0c8\uc2dc\uc7a5\uc744 \uc720\uc9c0\ud558\uace0 \uc788\uc73c\uba70, \ud76c\uadc0 \uc720\uc804 \uc9c8\ud658\uc740 \uaddc\uc81c \uc6b0\uc120\uc21c\uc704\ub97c \ubc1b\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   \uc804\ub2ec \ubc29\uc2dd\ubcc4: \uc804\uc2e0 \uc8fc\uc785\uc774 2025\ub144 \ub9e4\ucd9c\uc758 46.36%\ub97c \ucc28\uc9c0\ud588\uc9c0\ub9cc, \uad6d\uc18c \uc804\ub2ec\uc740 25.18%\uc758 CAGR\ub85c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. \ucc99\uc218\uac15 \ub0b4 \uc811\uadfc\ubc95\uc740 \ubca1\ud130 \uc6a9\ub7c9\uc744 10\ubd84\uc758 1\ub85c \uc904\uc5ec \uba74\uc5ed\uc6d0\uc131 \uc704\ud5d8\uc744 \ub0ae\ucd94\uba70, \ub9dd\ub9c9\ud558 \uc218\uc220 \ud504\ub85c\ud1a0\ucf5c\uc740 \ud45c\uc900\ud654\ub418\uc5b4 \uc7ac\ud604 \uac00\ub2a5\ud55c \uacb0\uacfc\ub97c \ubcf4\uc7a5\ud569\ub2c8\ub2e4.<br \/>\n*   \ucd5c\uc885 \uc0ac\uc6a9\uc790\ubcc4: \ubcd1\uc6d0 \ubc0f \uc804\ubb38 \ud074\ub9ac\ub2c9\uc740 2025\ub144 \ub9e4\ucd9c\uc758 53.66%\ub97c \ucc28\uc9c0\ud558\uba70 \uc0c1\uc5c5\uc801 \ud22c\uc5ec \ud5c8\ube0c \uc5ed\ud560\uc744 \ud569\ub2c8\ub2e4. \ud559\uc220 \uae30\uad00\uc740 \ucd08\uae30 \ud601\uc2e0\uc744 \uc8fc\ub3c4\ud558\uba70 26.64%\uc758 CAGR\uc744 \ubcf4\uc77c \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. \uc720\ub7fd \ucc38\uc870 \ub124\ud2b8\uc6cc\ud06c(ERN)\ub294 \ud76c\uadc0 \uc9c8\ud658 \uc0ac\ub840\ub97c \ud1b5\ud569\ud558\uc5ec \uc5f0\uad6c\ub97c \uac15\ud654\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p># \uc9c0\uc5ed \ubd84\uc11d<\/p>\n<p>*   \ubd81\ubbf8: 2024\ub144 \ub9e4\ucd9c\uc758 41.36%\ub97c \ucc28\uc9c0\ud558\uba70 \uac00\uc7a5 \ud070 \uc2dc\uc7a5\uc744 \uc720\uc9c0\ud588\uc2b5\ub2c8\ub2e4. 45\uac1c\uc758 \uc0c8\ub85c\uc6b4 RMAT(\uc7ac\uc0dd\uc758\ud559 \ucca8\ub2e8\uce58\ub8cc\uc81c) \uc9c0\uc815\uacfc CMS \uc811\uadfc \ubaa8\ub378\uc774 \uba54\ub514\ucf00\uc774\ub4dc \uc7a5\ubcbd\uc744 \uc644\ud654\ud558\ub294 \ub370 \uae30\uc5ec\ud588\uc2b5\ub2c8\ub2e4. \ub860\uc790, \uce74\ud0c8\ub80c\ud2b8, \ub808\uc9c8\ub9ac\uc5b8\uc2a4(Resilience) \ub4f1 \uc8fc\uc694 \uae30\uc5c5\uc758 \ub300\uaddc\ubaa8 \ubc14\uc774\uc624\ub9ac\uc561\ud130 \uc2dc\uc124\uc740 \uc774 \uc9c0\uc5ed\uc758 \uacf5\uae09 \uc6b0\uc704\ub97c \ud655\uace0\ud788 \ud569\ub2c8\ub2e4.<br \/>\n*   \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591: 28.78%\uc758 \uac00\uc7a5 \ub192\uc740 CAGR\ub85c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. \uc911\uad6d NMPA\uc758 \ub85d\ud0c0\ube44\uc548(Roctavian) \ubc0f \uc608\uc2a4\uce74\ud0c0(Yescarta) \uc2b9\uc778\uacfc 200\uac1c \uc774\uc0c1\uc758 \ud65c\uc131 \uc784\uc0c1 \uc2dc\ud5d8\uc774\uc774 \uc9c0\uc5ed\uc758 \uc131\uc7a5\uc744 \uac00\uc18d\ud654\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ud55c\uad6d\uc740 \uc138\ud3ec \ubc0f \uc720\uc804\uc790 \uce58\ub8cc\uc81c(CGT) \uac1c\ubc1c\uc744 \uc704\ud55c 10\ub144 \ub85c\ub4dc\ub9f5\uc744 \ubc1c\ud45c\ud588\uc73c\uba70, \uc77c\ubcf8\uc740 2024\ub144 1\uc6d4\uc5d0 100\uac1c \uc774\uc0c1\uc758 CGT \uc784\uc0c1 \uc2dc\ud5d8\uc744 \uc9c4\ud589\ud588\uc2b5\ub2c8\ub2e4.<\/p>\n<p>*   \uc720\ub7fd: 2024\ub144 \ub9e4\ucd9c\uc758 20.25%\ub97c \ucc28\uc9c0\ud588\uc2b5\ub2c8\ub2e4. \uc720\ub7fd \uc758\uc57d\ud488\uccad(EMA)\uc740 2023\ub144\uc5d0 10\uac1c\uc758 CGT\ub97c \uc2b9\uc778\ud588\uc73c\uba70, \uc774\ub294 2022\ub144\uc758 3\uac1c\uc5d0\uc11c \ud06c\uac8c \uc99d\uac00\ud55c \uc218\uce58\uc785\ub2c8\ub2e4. \ub3c5\uc77c\uc740 2024\ub144 1\uc6d4\uc5d0 50\uac1c \uc774\uc0c1\uc758 CGT \uc784\uc0c1 \uc2dc\ud5d8\uc744 \uc9c4\ud589\ud558\uba70 \uc774 \uc9c0\uc5ed\uc744 \uc120\ub3c4\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p># \uacbd\uc7c1 \ud658\uacbd<\/p>\n<p>\uc138\ud3ec \ubc0f \uc720\uc804\uc790 \uce58\ub8cc\uc81c \uc2dc\uc7a5\uc740 \uacbd\uc7c1\uc774 \uce58\uc5f4\ud558\uba70, \uc8fc\uc694 \uae30\uc5c5\ub4e4\uc740 \ud601\uc2e0\uc801\uc778 \uce58\ub8cc\ubc95 \uac1c\ubc1c\uacfc \uc2dc\uc7a5 \uc810\uc720\uc728 \ud655\ub300\ub97c \uc704\ud574 \ub178\ub825\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc8fc\uc694 \uae30\uc5c5\uc73c\ub85c\ub294 \ub178\ubc14\ud2f0\uc2a4(Novartis), \uae38\ub9ac\uc5b4\ub4dc \uc0ac\uc774\uc5b8\uc2a4(Gilead Sciences), \ube14\ub8e8\ubc84\ub4dc \ubc14\uc774\uc624(bluebird bio), \uc0ac\ub178\ud53c(Sanofi), \ubc14\uc774\uc624\uc820(Biogen), \ub85c\uc288(Roche), \uc544\uc2a4\ud154\ub77c\uc2a4 \ud30c\ub9c8(Astellas Pharma), \uc874\uc2a8\uc564\ub4dc\uc874\uc2a8(Johnson &#038; Johnson), \ubca0\ub9c1\uac70 \uc778\uac94\ud558\uc784(Boehringer Ingelheim), \uadf8\ub9ac\uace0 \ub2e4\ucf00\ub2e4 \uc81c\uc57d(Takeda Pharmaceutical) \ub4f1\uc774 \uc788\uc2b5\ub2c8\ub2e4. \uc774\ub4e4 \uae30\uc5c5\uc740 \uc5f0\uad6c \uac1c\ubc1c\uc5d0 \ub9c9\ub300\ud55c \ud22c\uc790\ub97c \ud558\uace0 \uc788\uc73c\uba70, \uc804\ub7b5\uc801 \ud30c\ud2b8\ub108\uc2ed, \uc778\uc218 \ud569\ubcd1, \uadf8\ub9ac\uace0 \ub77c\uc774\uc120\uc2a4 \uacc4\uc57d\uc744 \ud1b5\ud574 \ud30c\uc774\ud504\ub77c\uc778\uc744 \uac15\ud654\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ub610\ud55c, \uc81c\uc870 \uc5ed\ub7c9 \ud655\ucda9\uacfc \uacf5\uae09\ub9dd \ucd5c\uc801\ud654\ub97c \ud1b5\ud574 \uc2dc\uc7a5 \uc218\uc694\uc5d0 \ub300\uc751\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\ubcf8 \ubcf4\uace0\uc11c\ub294 \uc720\uc804\uc790 \uce58\ub8cc \uc2dc\uc7a5\uc5d0 \ub300\ud55c \ud3ec\uad04\uc801\uc778 \ubd84\uc11d\uc744 \uc81c\uacf5\ud558\uba70, \uc720\uc804\uc801 \ub610\ub294 \ud6c4\ucc9c\uc801 \uc9c8\ud658\uc744 \uad50\uc815\ud558\uae30 \uc704\ud574 \ubc14\uc774\ub7ec\uc2a4 \ub610\ub294 \ube44\ubc14\uc774\ub7ec\uc2a4 \ubca1\ud130\ub97c \uc0ac\uc6a9\ud558\uc5ec \uc720\uc804 \ubb3c\uc9c8\uc744 \uc0bd\uc785, \uce68\ubb35 \ub610\ub294 \ud3b8\uc9d1\ud558\ub294 \uce58\ub8cc\ubc95\uc5d0\uc11c \ubc1c\uc0dd\ud558\ub294 \uc218\uc775\uc744 \uc2dc\uc7a5\uc73c\ub85c \uc815\uc758\ud569\ub2c8\ub2e4. \uc790\uac00 \uc904\uae30\uc138\ud3ec \uc8fc\uc785\uacfc \uac19\uc774 \uc9c1\uc811\uc801\uc778 \uc720\uc804\uccb4 \ubcc0\ud615 \uc5c6\uc774 \uc138\ud3ec\ub97c \uc870\uc791\ud558\ub294 \uce58\ub8cc\ubc95\uc740 \ubc94\uc704\uc5d0\uc11c \uc81c\uc678\ub429\ub2c8\ub2e4.<\/p>\n<p>\uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc131\uc7a5 \uc608\uce21\uc5d0 \ub530\ub974\uba74, \uc720\uc804\uc790 \uce58\ub8cc \uc2dc\uc7a5\uc740 2026\ub144 100\uc5b5 4\ucc9c\ub9cc \ub2ec\ub7ec\uc5d0\uc11c 2031\ub144 258\uc5b5 9\ucc9c\ub9cc \ub2ec\ub7ec\ub85c \uc5f0\ud3c9\uade0 20.86%\uc758 \uacac\uace0\ud55c \uc131\uc7a5\ub960\uc744 \uae30\ub85d\ud560 \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4.<\/p>\n<p>\uc8fc\uc694 \uc2dc\uc7a5 \ub3d9\ub825\uc73c\ub85c\ub294 \uc77c\ud68c\uc131 \uc644\uce58 \uce58\ub8cc\uc81c\uc758 \uc2b9\uc778 \uc99d\uac00, \ucd08\ud76c\uadc0 \uc9c8\ud658\uc5d0 \ub300\ud55c \ubcf4\ud5d8 \uc801\uc6a9 \ud655\ub300, \uc544\ub370\ub178 \uad00\ub828 \ubc14\uc774\ub7ec\uc2a4(AAV) \ubc0f \ub80c\ud2f0\ubc14\uc774\ub7ec\uc2a4(LV) \uc81c\uc870 \ud50c\ub7ab\ud3fc\uc758 \ud45c\uc900\ud654, \ubca4\ucc98 \ubc0f SPAC(\uae30\uc5c5\uc778\uc218\ubaa9\uc801\ud68c\uc0ac) \uc790\uae08 \uc870\ub2ec \ud30c\uc774\ud504\ub77c\uc778\uc758 \uc131\uc7a5, CRISPR \uae30\ubc18 \uc0dd\uccb4 \ub0b4(in Vivo) \ud3b8\uc9d1 \uae30\uc220\uc758 \ubc1c\uc804, \uadf8\ub9ac\uace0 \ud76c\uadc0 \uc9c8\ud658 \uc720\uc804\uc790 \uce58\ub8cc\uc758 \ud3ec\ud568 \ud655\ub300 \ub4f1\uc774 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\ubc18\uba74, \ub192\uc740 \uc81c\uc870\uc6d0\uac00(COGS)\uc640 \uace0\uac00 \uce58\ub8cc\uc81c\uc5d0 \ub300\ud55c \ubc18\ubc1c, \ubcf5\uc7a1\ud55c \uc7a5\uae30 \uc548\uc804\uc131 \ubaa8\ub2c8\ud130\ub9c1 \uc758\ubb34, \uc804 \uc138\uacc4\uc801\uc778 \ubc14\uc774\ub7ec\uc2a4 \ubca1\ud130 \uc0dd\uc0b0 \uc5ed\ub7c9 \ubcd1\ubaa9 \ud604\uc0c1, \uadf8\ub9ac\uace0 \uc720\uc804\uc790 \ud3b8\uc9d1 \ud398\uc774\ub85c\ub4dc\uc5d0 \ub300\ud55c \ud2b9\ud5c8 \uc9d1\uc911 \ud604\uc0c1 \ub4f1\uc740 \uc2dc\uc7a5 \uc131\uc7a5\uc744 \uc800\ud574\ud558\ub294 \uc8fc\uc694 \uc694\uc778\uc73c\ub85c \uc791\uc6a9\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uc2dc\uc7a5\uc740 \uce58\ub8cc \uc720\ud615(\uc0dd\uccb4 \ub0b4\/\uc0dd\uccb4 \uc678), \ubca1\ud130 \uc720\ud615(\ubc14\uc774\ub7ec\uc2a4\/\ube44\ubc14\uc774\ub7ec\uc2a4), \uc801\uc751\uc99d(\uc885\uc591\ud559, \ud76c\uadc0 \uc720\uc804 \uc9c8\ud658, \uc548\uacfc, \ud608\uc561\ud559, \uc2e0\uacbd\ud559, \uc2ec\ud608\uad00 \ubc0f \uae30\ud0c0), \uc804\ub2ec \ubc29\uc2dd(\uc804\uc2e0 \ud22c\uc5ec\/\uad6d\uc18c \ud22c\uc5ec), \ucd5c\uc885 \uc0ac\uc6a9\uc790(\ubcd1\uc6d0 \ubc0f \uc804\ubb38 \ud074\ub9ac\ub2c9, \ud559\uc220 \ubc0f \uc5f0\uad6c \uae30\uad00 \ub4f1), \uadf8\ub9ac\uace0 \uc9c0\uc5ed\ubcc4(\ubd81\ubbf8, \uc720\ub7fd, \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591, \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74, \ub0a8\ubbf8)\ub85c \uc138\ubd84\ud654\ud558\uc5ec \uc2ec\uce35 \ubd84\uc11d\ub429\ub2c8\ub2e4. \ud2b9\ud788 \uc0dd\uccb4 \uc678(Ex vivo) \uce58\ub8cc\ubc95\uc740 \ub3d9\uc885 CAR-T \ud504\ub85c\uadf8\ub7a8\uc5d0 \ud798\uc785\uc5b4 21.97%\uc758 \uac00\uc7a5 \ube60\ub978 \uc5f0\ud3c9\uade0 \uc131\uc7a5\ub960\uc744 \ubcf4\uc77c \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. \uc9c0\uc5ed\ubcc4\ub85c\ub294 \uc911\uad6d, \uc77c\ubcf8, \ud55c\uad6d\uc758 \uaddc\uc81c \uacbd\ub85c \uc815\ub82c \ubc0f \uc81c\uc870 \uc5ed\ub7c9 \uad6c\ucd95\uc5d0 \ub530\ub77c \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591 \uc9c0\uc5ed\uc774 28.78%\uc758 \uac00\uc7a5 \ub192\uc740 \uc131\uc7a5\ub960\uc744 \uae30\ub85d\ud560 \uc804\ub9dd\uc785\ub2c8\ub2e4.<\/p>\n<p>\uc9c0\ubd88\uc790\ub4e4\uc740 \uc131\uacfc \uae30\ubc18 \uacc4\uc57d\uacfc \uc7a5\uae30\uc801\uc778 \ud61c\ud0dd\uc744 \uc785\uc99d\ud558\ub294 \uc2e4\uc81c \uc99d\uac70\ub97c \ud1b5\ud574 \uace0\uac00\uc758 \uc720\uc804\uc790 \uce58\ub8cc\uac00 \ud3c9\uc0dd \uc9c8\ubcd1 \uad00\ub9ac \ube44\uc6a9\uc744 \uc0c1\uc1c4\ud560 \uc218 \uc788\uc74c\uc744 \ub0a9\ub4dd\ud558\uace0 \uc788\uc73c\uba70, \uc774\ub294 \uc2dc\uc7a5 \ud655\uc7a5\uc5d0 \uae0d\uc815\uc801\uc778 \uc601\ud5a5\uc744 \ubbf8\uce58\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uacbd\uc7c1 \ud658\uacbd \ubd84\uc11d\uc740 \uc2dc\uc7a5 \uc9d1\uc911\ub3c4, \uc2dc\uc7a5 \uc810\uc720\uc728 \ubd84\uc11d, \uadf8\ub9ac\uace0 Amgen, Novartis, Pfizer \ub4f1 \uc8fc\uc694 24\uac1c \uae30\uc5c5\uc758 \uae00\ub85c\ubc8c \ubc0f \uc2dc\uc7a5 \uc218\uc900 \uac1c\uc694, \ud575\uc2ec \ubd80\ubb38, \uc7ac\ubb34, \uc804\ub7b5 \uc815\ubcf4, \uc81c\ud488 \ubc0f \uc11c\ube44\uc2a4, \ucd5c\uadfc \uac1c\ubc1c \uc0ac\ud56d\uc744 \ud3ec\ud568\ud55c \uc0c1\uc138 \ud504\ub85c\ud544\uc744 \uc81c\uacf5\ud569\ub2c8\ub2e4.<\/p>\n<p>\ubcf8 \ubcf4\uace0\uc11c\ub294 \uaddc\uc81c \uae30\uad00 \uac80\ud1a0\uc790, \ubcd1\uc6d0 \uc720\uc804\uc790 \uce58\ub8cc \uc57d\uc0ac, \ubca1\ud130 CDMO \uc784\uc6d0, \uc784\uc0c1 \uc5f0\uad6c\uc790\ub4e4\uacfc\uc758 \uc2ec\uce35 \uc778\ud130\ubdf0\ub97c \ud3ec\ud568\ud558\ub294 1\ucc28 \uc5f0\uad6c\uc640 FDA\/EMA \uc2b9\uc778 \ubaa9\ub85d, \uc784\uc0c1\uc2dc\ud5d8 \uc815\ubcf4, \uc0b0\uc5c5 \uc7ac\ubb34 \ub370\uc774\ud130 \ub4f1\uc744 \ud65c\uc6a9\ud55c 2\ucc28 \uc5f0\uad6c\ub97c \uacb0\ud569\ud55c \uc5c4\uaca9\ud55c \ubc29\ubc95\ub860\uc744 \ub530\ub985\ub2c8\ub2e4. \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc608\uce21\uc740 \uc9c8\ubcd1 \uc720\ubcd1\ub960, \uce58\ub8cc\uc81c \ucc44\ud0dd\ub960, \uc21c \ud310\ub9e4 \uac00\uaca9, \uc81c\uc870 \uc5ed\ub7c9, R&#038;D \uc790\uae08 \ub4f1 \uc8fc\uc694 \ubcc0\uc218\ub97c \uae30\ubc18\uc73c\ub85c \ud55c \uc0c1\ud5a5\uc2dd \ubc0f \ud558\ud5a5\uc2dd \uc811\uadfc \ubc29\uc2dd\uc744 \ud1b5\ud574 \uc774\ub8e8\uc5b4\uc84c\uc2b5\ub2c8\ub2e4. Mordor Intelligence\ub294 2025\ub144 \uc720\uc804\uc790 \uce58\ub8cc \uc2dc\uc7a5 \uaddc\ubaa8\ub97c 97\uc5b5 4\ucc9c\ub9cc \ub2ec\ub7ec\ub85c \ucd94\uc815\ud558\uba70, \uc774\ub294 \ud22c\uba85\ud558\uace0 \uc7ac\ud604 \uac00\ub2a5\ud55c \ubcc0\uc218\uc640 \ub2e8\uacc4\ub97c \uae30\ubc18\uc73c\ub85c \ud55c \uc2e0\ub8b0\ud560 \uc218 \uc788\ub294 \uae30\uc900\uc120\uc744 \uc81c\uacf5\ud569\ub2c8\ub2e4. \ubcf4\uace0\uc11c\ub294 \ub610\ud55c \uc2dc\uc7a5 \uae30\ud68c\uc640 \ubbf8\ub798 \uc804\ub9dd, \ud2b9\ud788 \ubbf8\ucda9\uc871 \uc218\uc694 \uc601\uc5ed\uc5d0 \ub300\ud55c \ud3c9\uac00\ub97c \ud3ec\ud568\ud569\ub2c8\ub2e4.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-29048","post","type-post","status-publish","format-standard","hentry","category-market-reports"],"_links":{"self":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts\/29048"}],"collection":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/comments?post=29048"}],"version-history":[{"count":0,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts\/29048\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/media?parent=29048"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/categories?post=29048"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/tags?post=29048"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}